Last reviewed · How we verify

NCT05658809

Intervention in Single Thyroid Nodule.

Status unknown NA Last updated 21 December 2022
What this trial tests

NA trial testing thyroidectomy in Thyroid Nodule in 40 participants. Status unknown.

Timeline
30 December 2022
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date30 December 2022
Primary completion30 December 2023
Estimated completion30 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 20 to 60, any sex, with Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thyroid nodules are common clinical problem. The incidence is 2-4 per 100,000 people per year, being more common in women and the elderly. thyroid nodule is a "discrete lesion within the thyroid gland that is radiologically distinct from the surrounding thyroid parenchyma. Most thyroid nodules are asymptomatic, may present as neck swelling

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of thyroidectomy

Trials testing the same drug.

Other recruiting trials for Thyroid Nodule

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05658809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing